Pharma News

Abbott Receives FDA Approval for TriClip, a Medical Device for Repairing Tricuspid Regurgitation

Approval comes amid positive results from TRILUMINATE trial, which demonstrated improvement in 90% of participants treated for a leaky tricuspid heart valve.

Source link
#Abbott #Receives #FDA #Approval #TriClip #Medical #Device #Repairing #Tricuspid #Regurgitation

Related Articles

Leave a Reply

Your email address will not be published. Required fields are marked *